US 9260726
Targeted integration and expression on exogenous nucleic acid sequences
granted A61KA61K48/0008A61K48/005
Quick answer
US patent 9260726 (Targeted integration and expression on exogenous nucleic acid sequences) held by Sangamo Biosciences, Inc. expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Biosciences, Inc.
- Grant date
- Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K48/0008, A61K48/005, A61K48/0058